Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
Genetically Modified Viruses Vaccines by Design
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
47-76
Author(s):
John R. Stephenson
Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
77-111
Author(s):
M. James C. Crabbe and Henry W. Hepburne-Scott
The Mouse In Cancer Research Past, Present, Future
Journal:
Current Genomics
Volume:
2
Page:
1-26
Author(s):
K. Hunter and D. Cozma
SUBJECT INDEX TO VOLUME 1
Journal:
Current Genomics
Volume:
2
Page:
87-89
Author(s):
Publishers Science Bentham
Inhibition of Tumor Cell Invasiveness by Chemically Modified Tetracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
261-270
Author(s):
Y. Gu, M. H. Lee, J. E. Roemer, L. Musacchia, M. L. Golub and R. S. Simon
Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
135-153
Author(s):
John A. Manthey, Najla Guthrie and Karel Grohmann
The Discovery of the Potent and Selective Antitumour Agent 2-(4-Amino-3-methylphenyl)benzothiazole (DF 203) and Related Compounds
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
203-210
Author(s):
T. D. Bradshaw, M.F. G. Stevens and A. D. Westwell
Preclinical Evaluation of New Anthracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
9-13
Author(s):
G. Pratesi and S. V. Monestiroli
Nuclear Targeting and Retention of Anthracycline Antitumor Drugs in Sensitive and Resistant Tumor Cells
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
15-29
Author(s):
Dylan J. Taatjes and Tad H. Koch